In a merger of rare disease specialists, BioMarin has agreed to acquire Amicus Therapeutics for $4.8 billion. The California ...
The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types of ...
The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...
People taking captopril, fosinopril, or enalapril for high blood pressure or heart failure may be putting themselves at risk ...
Candidates preparing for JEE Advanced 2026 can download the official syllabus PDF from jeeadv.ac.in, released by IIT Roorkee.
The application is based on the successful outcome of the pivotal US Phase 3 ConfIdeS trial in highly sensitized patientsImlifidase is an enzyme that rapidly and efficiently cleaves all types ...
Insider.comNews Commentary – The FDA is moving to require just one clinical trial for new drug approvals, signaling a dramatic shift toward faster regulatory pathways that could accelerate oncology ...
Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...
With the UHN REB approval, issued through the Clinical Trials Ontario (CTO) Stream system, St. Michael’s Hospital in Toronto, Ontario will now proceed to complete operational approvals, training, and ...
Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...
Background In 2024, the UK National Institute of Health and Care Excellence (NICE) recommended TriageHF alerts as an option ...
Lund, Sweden, December 15, 2025. Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), today announced a reorganization of its European and International Commercial and Medical Affairs operations, eff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback